Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eger

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The FEBS Journal|March 31, 2015
The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidaseTomoko Nishino, Ken Okamoto, Yuko Kawaguchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2003
Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductaseYoshimitsu Kuwabara, Tomoko Nishino, Ken Okamoto, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2000
Purification, crystallization and preliminary X-ray diffraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milkB T Eger, K Okamoto, C Enroth, et al.
Biochemistry|February 21, 1998
Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexesV S Stoll, B T Eger, R C Hynes, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2004
Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretionAtsushi Fukunari, Ken Okamoto, Takeshi Nishino, et al.
The Journal of Biological Chemistry|May 10, 2005
Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutantTomoko Nishino, Ken Okamoto, Yuko Kawaguchi, et al.
Plos One|January 21, 2017
Novel Tools in Determining the Physiological Demands and Nutritional Practices of Ontario FireRangers during Fire DeploymentsA H Robertson, C Larivière, C R Leduc, et al.
Biochemistry|February 5, 1991
Mechanism of DNA replication fidelity for three mutants of DNA polymerase I: Klenow fragment KF(exo+), KF(polA5), and KF(exo-)B T Eger, R D Kuchta, S S Carroll, et al.
Journal of Clinical Microbiology|October 1, 1994
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosisD van Soolingen, P E de Haas, J Haagsma, et al.
Journal of Molecular Biology|August 19, 2018
A Novel Polar Core and Weakly Fixed C-Tail in Squid Arrestin Provide New Insight into Interaction with RhodopsinAbhishek Bandyopadhyay, Ned Van Eps, Bryan T Eger, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The FEBS Journal|March 31, 2015
The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidaseTomoko Nishino, Ken Okamoto, Yuko Kawaguchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2003
Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductaseYoshimitsu Kuwabara, Tomoko Nishino, Ken Okamoto, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 28, 2000
Purification, crystallization and preliminary X-ray diffraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milkB T Eger, K Okamoto, C Enroth, et al.
Biochemistry|February 21, 1998
Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexesV S Stoll, B T Eger, R C Hynes, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2004
Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretionAtsushi Fukunari, Ken Okamoto, Takeshi Nishino, et al.
The Journal of Biological Chemistry|May 10, 2005
Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutantTomoko Nishino, Ken Okamoto, Yuko Kawaguchi, et al.
Plos One|January 21, 2017
Novel Tools in Determining the Physiological Demands and Nutritional Practices of Ontario FireRangers during Fire DeploymentsA H Robertson, C Larivière, C R Leduc, et al.
Biochemistry|February 5, 1991
Mechanism of DNA replication fidelity for three mutants of DNA polymerase I: Klenow fragment KF(exo+), KF(polA5), and KF(exo-)B T Eger, R D Kuchta, S S Carroll, et al.
Journal of Clinical Microbiology|October 1, 1994
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosisD van Soolingen, P E de Haas, J Haagsma, et al.
Journal of Molecular Biology|August 19, 2018
A Novel Polar Core and Weakly Fixed C-Tail in Squid Arrestin Provide New Insight into Interaction with RhodopsinAbhishek Bandyopadhyay, Ned Van Eps, Bryan T Eger, et al.
Pageof 6